CXorf61 is a target for T cell based immunotherapy of triple-negative breast cancer
about
Exosomes for Immunoregulation and Therapeutic Intervention in Cancerγδ T cells in cancer immunotherapyGeneration of V α13/β21+T cell specific target CML cells by TCR gene transfer.Effectors and potential targets selectively upregulated in human KRAS-mutant lung adenocarcinomas.Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer.Early gastric cancer frequently has high expression of KK-LC-1, a cancer-testis antigen.Expression of KK-LC-1, a cancer/testis antigen, at non-tumour sites of the stomach carrying a tumour.
P2860
Q26744193-95ADC5B5-2FB3-471C-AA70-4F21CBE66182Q28068988-ECDDF24E-625B-48C0-B28F-912056BB804AQ37708939-B2BA10CD-1AFF-4CD8-BB9E-644A2AF95453Q39683637-D711091E-827A-466B-937D-D1A74DCB1451Q40242985-77AF3408-E596-4513-BA8B-F9837272FDD9Q47157952-E11AF81B-1760-4396-84D2-07F43071FCEAQ54215693-5F6614E1-4D76-4F90-B1D9-569FBD3921F5
P2860
CXorf61 is a target for T cell based immunotherapy of triple-negative breast cancer
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
CXorf61 is a target for T cell based immunotherapy of triple-negative breast cancer
@ast
CXorf61 is a target for T cell based immunotherapy of triple-negative breast cancer
@en
type
label
CXorf61 is a target for T cell based immunotherapy of triple-negative breast cancer
@ast
CXorf61 is a target for T cell based immunotherapy of triple-negative breast cancer
@en
prefLabel
CXorf61 is a target for T cell based immunotherapy of triple-negative breast cancer
@ast
CXorf61 is a target for T cell based immunotherapy of triple-negative breast cancer
@en
P2093
P2860
P356
P1433
P1476
CXorf61 is a target for T cell based immunotherapy of triple-negative breast cancer
@en
P2093
Abderaouf Selmi
Andrea Breitkreuz
Anne Kölsch
Christian Bender
Christoph Hartmann
Claudia Paret
Diana Barea Roldan
Kirsten Vormbrock
Meike Wagner
Petra Simon
P2860
P304
25356-25367
P356
10.18632/ONCOTARGET.4516
P407
P50
P577
2015-09-01T00:00:00Z